By Type
- Airborne Particle Counters
- Portable
- Remote
- Handheld
- Condensation/Ultrafine
- Liquid Particle Counters
By Application
- Clean Room Monitoring
- Drinking Water Contamination Monitoring
- Aerosol Monitoring and Research
- Indoor Air Quality Monitoring
- Contamination Monitoring of Liquid
- Chemical Contamination Monitoring
- Other Applications
By End User
- Life Science and Medical Device Industry
- Semiconductor Industry
- Automotive Industry
- Aerospace Industry
- Food and Beverage Industry
- Other End Users
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
The market is fragmented into type, application, end user and region. The type segment is categorised into airborne particle counters and liquid particle counters. The airborne particle counters segment is further divided into portable, remote, handheld and condensation/ultrafine while the liquid particle counter segment is classified into online and offline liquid particle counters. The airborne particle counter segment held the largest particle counter market share, and this can be credited to the rising usage of these counters for monitoring cleanrooms and the increased stringency in monitoring air pollution. The application segment is divided into indoor air quality monitoring, cleanroom monitoring, drinking water contamination monitoring, aerosol monitoring and research, chemical contamination monitoring, liquid contamination monitoring and other applications. The cleanroom monitoring segment is poised to lead the market owing to its wide range of applications in semiconductor and pharmaceutical industries.
The end user segment is fragmented into life science and medical device industry, automotive industry, semiconductor industry, food and beverage industry, aerospace industry and other end users. The life science and medical device industry segment is anticipated to dominate the market during the forecast period and this can be attributed to the increased compound volumes for identifying the presence of impurity in samples, soaring production levels of pharmaceutical formulations, stringency in safe rules and regulations, increased pharma outsourcing from the Asian region and rising expenditure on research and development.
The Asia Pacific region is anticipated to proliferate during the forecasted timeframe and this can be credited to a remarkable augmentation in the food
beverage testing, medical device and pharmaceutical industries, growing funds for research and development, rise in the number of CROs and favourable initiatives implemented by the government for promoting biopharmaceutical and pharma industries.